{"id":"cetylpyridinium","rwe":[{"pmid":"41867590","year":"2026","title":"Kaolin-Gallic Acid Functionalized Gamma-Chitosan/Alginate Beads: A Novel Material for Chlorhexidine and Cetylpyridinium Elimination from Dental Effluents.","finding":"","journal":"ACS omega","studyType":"Clinical Study"},{"pmid":"41862273","year":"2026","title":"Antiviral effect of cetylpyridinium chloride on SARS-CoV-2 in patients with COVID-19: An Observational Study.","finding":"","journal":"Journal of oral biosciences","studyType":"Clinical Study"},{"pmid":"41852227","year":"2026","title":"Interaction of Bile Salts, Surfactants, and Their Mixtures with the Phosphatidylcholine(d(62)) Lipid Monolayer/Water Interface Probed by VSFG Spectroscopy.","finding":"","journal":"Langmuir : the ACS journal of surfaces and colloids","studyType":"Clinical Study"},{"pmid":"41851409","year":"2026","title":"Structural and dynamic characterisation of charged microemulsions grafted with telechelic polymers at high dilution.","finding":"","journal":"The European physical journal. E, Soft matter","studyType":"Clinical Study"},{"pmid":"41843575","year":"2026","title":"Effect of Cationic Surfactants on the Molecular Organization of the Simplified Model Lipid Envelope of SARS-CoV-2 Virus─Insights from the Langmuir Monolayer and Liposome Studies.","finding":"","journal":"Langmuir : the ACS journal of surfaces and colloids","studyType":"Clinical Study"}],"_fda":{"id":"49ef6843-fbfb-84f2-e063-6294a90a1c77","set_id":"0162bc02-9c93-4f15-883c-68794c92e64d","openfda":{"unii":["D9OM4SK49P"],"route":["ORAL"],"rxcui":["1100924"],"spl_id":["49ef6843-fbfb-84f2-e063-6294a90a1c77"],"brand_name":["Antispetic"],"spl_set_id":["0162bc02-9c93-4f15-883c-68794c92e64d"],"package_ndc":["53942-299-86"],"product_ndc":["53942-299"],"generic_name":["CETYLPYRIDINIUM CHLORIDE"],"product_type":["HUMAN OTC DRUG"],"substance_name":["CETYLPYRIDINIUM CHLORIDE"],"manufacturer_name":["Demoulas Super Markets, Inc"],"application_number":["505G(a)(3)"],"is_original_packager":[true]},"purpose":["Purpose Antigingivitis, Antiplaque"],"version":"14","stop_use":["Stop use and ask a dentist if gingivitis, gleeding or redness persists for more than 2 weeks you have painful or swollen gums, pus from the gum line, loose teeth or increased spacing between the teeth. These may be signs or symptoms of periodontitis, a serious form of gum disease."],"warnings":["Warnings for this product"],"effective_time":"20260203","active_ingredient":["Active ingredient Cetylpyridinium chloride 0.07%"],"adverse_reactions":["ADVERSE REACTION DISTRIBUTED BY DEMOULAS SUPER MARKETS, INC. 875 EAST STREET TEWKSBURY, MA 01876"],"inactive_ingredient":["Inactive ingredients water, glycerin, flavor, poloxamer 188, sodium saccharin, propylene glycol, sodium benzoate, sucralose, benzoic acid, blue 1"],"indications_and_usage":["Use helps control plaque that leads to gingivitis"],"spl_unclassified_section":["Claims For better oral hygiene and fresher breath","Other information this rinse is not intended to replace brushing or flossing","Disclaimers This rinse may cause temporary staining to the surface of teeth. This is not harmful, and adequate brushing may prevent its occurrence. *This product is not manufactured or distributed by Procter & Gamble, distributor of Crest ® Pro-Health Multi-Protection Alcohol Free Rinse - Refreshing Clean Mint"],"dosage_and_administration":["Directions adults and children 6 years & older: rinse for 30 seconds with 20 mL (4 teaspoonfuls) twice a day do not swallow children 6 years to under 12 years of age: supervise use when used after brushing, rinse mouth with water first children under 6 years of age: do not use"],"spl_product_data_elements":["Antispetic Cetylpyridinium chloride WATER GLYCERIN POLOXAMER 188 SACCHARIN SODIUM PROPYLENE GLYCOL SODIUM BENZOATE SUCRALOSE BENZOIC ACID FD&C BLUE NO. 1 CETYLPYRIDINIUM CHLORIDE CETYLPYRIDINIUM"],"keep_out_of_reach_of_children":["Keep out of reach of children under 6 years of age. If more than used for rinsing is accidentally swallowed, get medical help or contact a Poison Control Center right away."],"package_label_principal_display_panel":["principal display panel \"MORE FOR YOUR DOLLAR\" MARKET BASKET ® Sealed with printed neckband for your protection Compare to active ingredient in Crest ® Pro-Health Rinse* Mulit-Action Alcohol-Free Antiseptic Oral Rinse with CPC Antigingivitis/Antiplaque KILLS GERMS HELPS PREVENT PLAQUE HELPS PREVENT GINGIVITIS HELPS KEEP TEETH FEELING CLEAN FRESHENS BREATH NO BURN OF ALCOHOL Zesty Mint 1 L (33.8 FL OZ) image description image description"]},"tags":[{"label":"cetylpyridinium","category":"class"},{"label":"Small Molecule","category":"modality"},{"label":"Caspase-2","category":"target"},{"label":"CASP2","category":"gene"},{"label":"B05CA01","category":"atc"},{"label":"Extracorporeal","category":"route"},{"label":"Topical","category":"route"},{"label":"Oral","category":"route"},{"label":"Cloth","category":"form"},{"label":"Liquid","category":"form"},{"label":"Active","category":"status"},{"label":"Local anesthesia","category":"indication"},{"label":"Mouth Irritation","category":"indication"},{"label":"Suppression of the Gag Reflex","category":"indication"},{"label":"Anti-Infective Agents","category":"pharmacology"},{"label":"Anti-Infective Agents, Local","category":"pharmacology"},{"label":"Detergents","category":"pharmacology"},{"label":"Surface-Active Agents","category":"pharmacology"}],"phase":"marketed","safety":{"boxedWarnings":[],"safetySignals":[{"date":"","signal":"DYSPNOEA","source":"FDA FAERS","actionTaken":"49 reports"},{"date":"","signal":"NAUSEA","source":"FDA FAERS","actionTaken":"45 reports"},{"date":"","signal":"PAIN","source":"FDA FAERS","actionTaken":"41 reports"},{"date":"","signal":"FATIGUE","source":"FDA FAERS","actionTaken":"39 reports"},{"date":"","signal":"COUGH","source":"FDA FAERS","actionTaken":"32 reports"},{"date":"","signal":"VOMITING","source":"FDA FAERS","actionTaken":"32 reports"},{"date":"","signal":"AGEUSIA","source":"FDA FAERS","actionTaken":"31 reports"},{"date":"","signal":"SEPSIS","source":"FDA FAERS","actionTaken":"29 reports"},{"date":"","signal":"ORAL PAIN","source":"FDA FAERS","actionTaken":"27 reports"},{"date":"","signal":"PNEUMONIA","source":"FDA FAERS","actionTaken":"27 reports"}],"commonSideEffects":[{"effect":"Gastrointestinal toxicity","drugRate":"","severity":"common","_validated":false,"_confidence":0.3},{"effect":"Pulmonary toxicity","drugRate":"","severity":"common","_validated":false,"_confidence":0.3},{"effect":"Joint injury","drugRate":"","severity":"common","_validated":false,"_confidence":0.3},{"effect":"Neoplasm malignant","drugRate":"","severity":"common","_validated":false,"_confidence":0.3},{"effect":"C-reactive protein abnormal","drugRate":"","severity":"common","_validated":false,"_confidence":0.3},{"effect":"Hepatotoxicity","drugRate":"","severity":"common","_validated":false,"_confidence":0.3},{"effect":"Therapy non-responder","drugRate":"","severity":"common","_validated":false,"_confidence":0.3},{"effect":"Joint stiffness","drugRate":"","severity":"common","_validated":false,"_confidence":0.3},{"effect":"Musculoskeletal pain","drugRate":"","severity":"common","_validated":false,"_confidence":0.3},{"effect":"Musculoskeletal stiffness","drugRate":"","severity":"common","_validated":false,"_confidence":0.3},{"effect":"Therapeutic product effect incomplete","drugRate":"","severity":"common","_validated":false,"_confidence":0.3},{"effect":"Treatment failure","drugRate":"","severity":"common","_validated":false,"_confidence":0.3},{"effect":"Drug hypersensitivity","drugRate":"","severity":"common","_validated":false,"_confidence":0.3},{"effect":"Infection","drugRate":"","severity":"common","_validated":false,"_confidence":0.3},{"effect":"Arthropathy","drugRate":"","severity":"common","_validated":false,"_confidence":0.3}],"contraindications":["Anemia due to enzyme deficiency","Deficiency of cytochrome-b>5< reductase","Deficiency of glucose-6-phosphate dehydrogenase","Hypocupremia","Methemoglobinemia"]},"trials":[],"aliases":[],"patents":[],"pricing":[],"_sources":{"trials":{"url":"https://clinicaltrials.gov/search?intr=CETYLPYRIDINIUM","method":"api_direct","source":"ClinicalTrials.gov","rawText":"","confidence":1,"sourceType":"ctgov","retrievedAt":"2026-04-20T00:18:48.202955+00:00"},"regulatory.ca":{"url":"","method":"api_direct","source":"Health Canada DPD","rawText":"","confidence":1,"sourceType":"health_canada_dpd","retrievedAt":"2026-04-20T00:18:54.702591+00:00"},"publicationCount":{"url":"https://pubmed.ncbi.nlm.nih.gov/?term=CETYLPYRIDINIUM","method":"api_direct","source":"PubMed/NCBI","rawText":"","confidence":1,"sourceType":"pubmed","retrievedAt":"2026-04-20T00:18:54.994381+00:00"},"administration.route":{"url":"","method":"deterministic","source":"FDA Label","rawText":"","confidence":1,"sourceType":"fda_label","retrievedAt":"2026-04-20T00:18:46.949434+00:00"},"safety.boxedWarnings":{"url":"","method":"deterministic","source":"FDA Label (no boxed warning)","rawText":"","confidence":1,"sourceType":"fda_label","retrievedAt":"2026-04-20T00:18:46.949482+00:00"},"safety.safetySignals":{"url":"https://api.fda.gov/drug/event.json","method":"api_direct","source":"FDA FAERS","rawText":"","confidence":1,"sourceType":"fda_faers","retrievedAt":"2026-04-20T00:18:56.596592+00:00"},"crossReferences.chemblId":{"url":"https://www.ebi.ac.uk/chembl/compound_report_card/CHEMBL2003538/","method":"api_direct","source":"ChEMBL (EMBL-EBI)","rawText":"","confidence":1,"sourceType":"chembl","retrievedAt":"2026-04-20T00:18:55.716270+00:00"},"regulatory.fda_application":{"url":"","method":"deterministic","source":"FDA Label","rawText":"505G(a)(3)","confidence":1,"sourceType":"fda_label","retrievedAt":"2026-04-20T00:18:46.949486+00:00"}},"allNames":"ceepryn","offLabel":[],"synonyms":["cetylpyridinium","ceepryn","hexadecylpyridinium","cetylpyridinium chloride"],"timeline":[],"approvals":[{"date":"","orphan":false,"company":"","regulator":"FDA"}],"brandName":"Ceepryn","ecosystem":[{"indication":"Local anesthesia","otherDrugs":[{"name":"amobarbital","slug":"amobarbital","company":""},{"name":"benzalkonium","slug":"benzalkonium","company":""},{"name":"benzocaine","slug":"benzocaine","company":""},{"name":"bupivacaine","slug":"bupivacaine","company":"Hospira"}],"globalPrevalence":null},{"indication":"Mouth Irritation","otherDrugs":[{"name":"benzalkonium","slug":"benzalkonium","company":""},{"name":"benzocaine","slug":"benzocaine","company":""},{"name":"dextromethorphan","slug":"dextromethorphan","company":"Ani Pharms"},{"name":"dyclonine","slug":"dyclonine","company":""}],"globalPrevalence":null},{"indication":"Suppression of the Gag Reflex","otherDrugs":[{"name":"benzalkonium","slug":"benzalkonium","company":""},{"name":"benzocaine","slug":"benzocaine","company":""},{"name":"dyclonine","slug":"dyclonine","company":""},{"name":"levomenthol","slug":"levomenthol","company":""}],"globalPrevalence":null}],"mechanism":{"target":"Caspase-2","novelty":"First-in-class","targets":[{"gene":"CASP2","source":"DrugCentral","target":"Caspase-2","protein":"Caspase-2"}],"modality":"Small Molecule","drugClass":"cetylpyridinium","explanation":"","oneSentence":"","technicalDetail":"Ceepryn exerts its effects by competitively inhibiting the activity of caspase-2, a cysteine protease involved in the apoptosis pathway and inflammation response."},"commercial":{},"references":[{"id":1,"url":"https://drugcentral.org/drugcard/3083","fields":["approvals","synonyms","ATC","PK","indications","contraindications","DDIs","targets","patents","FAERS"],"source":"DrugCentral"},{"id":2,"url":"https://clinicaltrials.gov/search?intr=CETYLPYRIDINIUM","fields":["trials"],"source":"ClinicalTrials.gov"},{"id":3,"url":"https://pubmed.ncbi.nlm.nih.gov/?term=CETYLPYRIDINIUM","fields":["publications"],"source":"PubMed/NCBI"}],"_enrichedAt":"2026-03-30T09:31:49.386082","_validation":{"fieldsValidated":0,"lastValidatedAt":"2026-04-20T00:18:58.293594+00:00","fieldsConflicting":16,"overallConfidence":0.8},"biosimilars":[],"competitors":[{"drugName":"chlorhexidine","drugSlug":"chlorhexidine","fdaApproval":"1976-09-17","patentExpiry":"Oct 2, 2027","patentStatus":"Patent protected","relationship":"same-class"},{"drugName":"nitrofurazone","drugSlug":"nitrofurazone","fdaApproval":"1945-10-04","genericCount":6,"patentStatus":"Off-patent — generic available","relationship":"same-class"},{"drugName":"sulfamethizole","drugSlug":"sulfamethizole","fdaApproval":"1953-10-28","genericCount":1,"patentStatus":"Off-patent — generic available","relationship":"same-class"},{"drugName":"neomycin","drugSlug":"neomycin","fdaApproval":"1957-03-26","genericCount":12,"patentStatus":"Off-patent — generic available","relationship":"same-class"}],"genericName":"cetylpyridinium","indications":{"approved":[{"name":"Local anesthesia","source":"DrugCentral","snomedId":386761002,"regulator":"FDA","eligibility":"No information available"},{"name":"Mouth Irritation","source":"DrugCentral","snomedId":"","regulator":"FDA","eligibility":"No information available"},{"name":"Suppression of the Gag Reflex","source":"DrugCentral","snomedId":"","regulator":"FDA","eligibility":"No information available"}],"offLabel":[],"pipeline":[]},"drugCategory":"active","labelChanges":[],"relatedDrugs":[{"drugId":"chlorhexidine","brandName":"chlorhexidine","genericName":"chlorhexidine","approvalYear":"1976","relationship":"same-class"},{"drugId":"nitrofurazone","brandName":"nitrofurazone","genericName":"nitrofurazone","approvalYear":"1945","relationship":"same-class"},{"drugId":"sulfamethizole","brandName":"sulfamethizole","genericName":"sulfamethizole","approvalYear":"1953","relationship":"same-class"},{"drugId":"neomycin","brandName":"neomycin","genericName":"neomycin","approvalYear":"1957","relationship":"same-class"}],"trialDetails":[{"nctId":"NCT07490873","phase":"NA","title":"Antiplaque Efficacy and Patient Reported Outcome of Chlorohexidine, Cetylpyridinium Chloride, and Essential Oil Mouthwashes in Orthodontic Patients","status":"RECRUITING","sponsor":"University of Baghdad","startDate":"2026-01-05","conditions":["Effectiveness of Chlorohexidine","Effectiveness of Essential Oil","Effectiveness of Cetylpyridinium Chloride"],"enrollment":24,"completionDate":"2026-10-01"},{"nctId":"NCT07489924","phase":"PHASE4","title":"Microbiological Effect of 0.12% Chlorhexidine Digluconate and 0.05% Cetylpyridinium Chloride vs Probiotics (Lactobacillus Reuteri Prodentis) on Porphyromonas Gingivalis.","status":"ACTIVE_NOT_RECRUITING","sponsor":"Universidad de Colima","startDate":"2023-01-08","conditions":["Periodontal Diseases","Diabetes Mellitus Type 2"],"enrollment":20,"completionDate":"2026-07-31"},{"nctId":"NCT06244303","phase":"PHASE3","title":"Clinical Research Study to Assess the Efficacy of Two Brushing Regimens in the Reduction of Established Dental Plaque and Gingivitis.","status":"COMPLETED","sponsor":"Colgate Palmolive","startDate":"2024-01-22","conditions":["Gingivitis","Plaque"],"enrollment":82,"completionDate":"2024-04-16"},{"nctId":"NCT06479226","phase":"PHASE3","title":"Effect of Mouthwash in Reducing the Symptoms Associated With Flu and Cold Viruses","status":"COMPLETED","sponsor":"Colgate Palmolive","startDate":"2022-06-05","conditions":["Healthy"],"enrollment":150,"completionDate":"2022-10-06"},{"nctId":"NCT06660069","phase":"NA","title":"A Study to Evaluate the Efficacy of a Stannous Fluoride Toothpaste With a Cetylpyridinium Chloride Mouthwash in Improving Gingival Health and Reducing Plaque Accumulation","status":"COMPLETED","sponsor":"HALEON","startDate":"2024-11-18","conditions":["Dental Plaque","Gingivitis"],"enrollment":199,"completionDate":"2025-03-11"},{"nctId":"NCT07430670","phase":"NA","title":"Theravex Oral and Theravex Tissue Care Plus in the Healing Process of Mucogingival Surgery","status":"RECRUITING","sponsor":"Universidad Complutense de Madrid","startDate":"2026-02-17","conditions":["Gingival Recession, Localized"],"enrollment":30,"completionDate":"2027-07-06"},{"nctId":"NCT07398846","phase":"PHASE3","title":"Efficacy of a Stannous Fluoride Toothpaste, Cetylpyridinium Chloride Mouthwash, and Battery Toothbrush Regimen in Reducing Established Dental Plaque and Gingivitis.","status":"RECRUITING","sponsor":"Colgate Palmolive","startDate":"2026-01-26","conditions":["Plaque"],"enrollment":135,"completionDate":"2026-04-20"},{"nctId":"NCT04931004","phase":"EARLY_PHASE1","title":"Oral Rinse to Reduced Expelled Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) During COVID-19 Infection","status":"COMPLETED","sponsor":"Rutgers, The State University of New Jersey","startDate":"2021-07-21","conditions":["Covid19"],"enrollment":34,"completionDate":"2022-12-31"},{"nctId":"NCT07351370","phase":"PHASE3","title":"Efficacy of Two Daily - Use CHX Based Mouth Rinses on Microbial Biofilm Accumulation, Gingivitis Development, and Staining","status":"COMPLETED","sponsor":"Dental School","startDate":"2022-01-15","conditions":["Mouthwashes","Chlorhexidine","Dental Plaque","Gingival and Periodontal Disease","Randomized Controlled Trial"],"enrollment":81,"completionDate":"2022-07-20"},{"nctId":"NCT07263698","phase":"PHASE3","title":"Investigation of Clinical Efficacy of a New Mouthwash on Reducing Dental Plaque and Helping Prevent Gum Problems as Compared to a Control Mouthwash","status":"ACTIVE_NOT_RECRUITING","sponsor":"Colgate Palmolive","startDate":"2025-12-01","conditions":["Gingivitis","Plaque, Dental"],"enrollment":80,"completionDate":"2026-03"},{"nctId":"NCT06770114","phase":"PHASE3","title":"Clinical Study to Investigate a New Mouthwash in Reducing Plaque and Helping Prevent Gum Problems on Dental Implants Over a 6-month Period of Product Use","status":"COMPLETED","sponsor":"Colgate Palmolive","startDate":"2021-10-18","conditions":["Gingivitis"],"enrollment":80,"completionDate":"2022-05-09"},{"nctId":"NCT06411522","phase":"NA","title":"Clinical and Microbiological Comparison of 0.12% CHX and 0.05% CHX+0.05%CPC Mouthwashes in TPS Patients","status":"COMPLETED","sponsor":"University of Siena","startDate":"2024-05-20","conditions":["Chlorhexidine","Gingivitis","Periodontitis","Cetylpyridinium Chloride"],"enrollment":72,"completionDate":"2025-10-18"},{"nctId":"NCT07211061","phase":"PHASE4","title":"A Study is to Evaluate a Regimen on Gingivitis Using Traditional and Novel Assessment Methods","status":"COMPLETED","sponsor":"Procter and Gamble","startDate":"2011-09-21","conditions":["Gingivitis"],"enrollment":69,"completionDate":"2011-11-10"},{"nctId":"NCT06933368","phase":"NA","title":"A Clinical Study to Evaluate the Efficacy of a Cetylpyridinium Chloride Mouthwash in Improving Gingival Health and Reducing Plaque Accumulation","status":"COMPLETED","sponsor":"HALEON","startDate":"2025-04-21","conditions":["Dental Plaque","Gingivitis"],"enrollment":136,"completionDate":"2025-08-14"},{"nctId":"NCT07088666","phase":"NA","title":"0.2% Chlorhexidine vs MicroRepair ABX in Gingivitis","status":"RECRUITING","sponsor":"University of Pavia","startDate":"2025-08-30","conditions":["Gingivitis and Periodontal Diseases","Dental Plaque","Oral Hygiene"],"enrollment":40,"completionDate":"2026-03-10"},{"nctId":"NCT07088653","phase":"NA","title":"Comparison of 0.12% Chlorhexidine and MicroRepair ABX Mouthwash in Gingivitis Management","status":"RECRUITING","sponsor":"University of Pavia","startDate":"2025-08-30","conditions":["Gingivitis","Dental Plaque","Gingival Inflammation"],"enrollment":40,"completionDate":"2026-03-10"},{"nctId":"NCT06859281","phase":"PHASE1","title":"Safety, Tolerability, and Pharmacokinetic Profile of Grammidin, a Metered Dose Topical Spray in Healthy Volunteers","status":"RECRUITING","sponsor":"Valenta Pharm JSC","startDate":"2024-12-10","conditions":["Pharyngitis"],"enrollment":24,"completionDate":"2026-12-01"},{"nctId":"NCT06857890","phase":"PHASE1","title":"Safety, Tolerability, and Pharmacokinetic Profile of Grammidin With Anesthetic, a Metered Dose Topical Spray in Healthy Volunteers","status":"RECRUITING","sponsor":"Valenta Pharm JSC","startDate":"2024-12-09","conditions":["Pharyngitis"],"enrollment":24,"completionDate":"2026-12-01"},{"nctId":"NCT06966817","phase":"NA","title":"The Effect of Two Different Oral Care Solutions on Ventilator-Associated Pneumonia and Oral Health of Mechanically Ventilated Patients in the Intensive Care Unit","status":"ENROLLING_BY_INVITATION","sponsor":"Saglik Bilimleri Universitesi","startDate":"2024-05-15","conditions":["Ventilator-associated Pneumonia and Oral Health"],"enrollment":60,"completionDate":"2025-08-15"},{"nctId":"NCT06967402","phase":"NA","title":"Comparative Effects of Two Oral Antiseptics Used as an Adjuvant in the Treatment of Periodontitis","status":"NOT_YET_RECRUITING","sponsor":"The University of Hong Kong","startDate":"2025-07","conditions":["Periodontitis","Periodontitis Stage II","Periodontitis Stage III"],"enrollment":60,"completionDate":"2026-12"},{"nctId":"NCT06607172","phase":"PHASE3","title":"Clinical Efficacy of the Combined Effect of Oral Irrigator and Chemicals (0.075% CPC)","status":"COMPLETED","sponsor":"Colgate Palmolive","startDate":"2024-09-30","conditions":["Dental Plaque","Dental Plaque Induced Gingivitis","Dental Plaque and Gingivitis","Gingivitis"],"enrollment":30,"completionDate":"2024-10-22"},{"nctId":"NCT05178173","phase":"NA","title":"Efficacy of Oral Rinses for Inactivation of COVID-19 (MOR2)","status":"COMPLETED","sponsor":"University of North Carolina, Chapel Hill","startDate":"2022-01-20","conditions":["COVID-19","Coronavirus Infection","SARS CoV 2 Infection"],"enrollment":230,"completionDate":"2023-07-12"},{"nctId":"NCT06251089","phase":"NA","title":"Effect of Cetylpyridinium Chloride (CPC) Rinse in Viral Upper Respiratory Tract Infections (vURTI)","status":"COMPLETED","sponsor":"Dentaid SL","startDate":"2023-11-15","conditions":["Viral Pharyngitis"],"enrollment":102,"completionDate":"2024-08-05"},{"nctId":"NCT06036472","phase":"NA","title":"Impact of Periodontal Therapy on Mental Health Parameters","status":"RECRUITING","sponsor":"Universidad Complutense de Madrid","startDate":"2024-03-14","conditions":["Periodontitis","Depression"],"enrollment":40,"completionDate":"2026-01"},{"nctId":"NCT04149327","phase":"PHASE4","title":"Systemic Amoxicillin Plus Metronidazole in Peri-implantitis Treatment","status":"COMPLETED","sponsor":"University Medical Center Groningen","startDate":"2012-08-01","conditions":["Peri-implantitis","Periodontal Diseases"],"enrollment":62,"completionDate":"2019-12"},{"nctId":"NCT01852253","phase":"NA","title":"Implant Surface Decontamination With 2 % Chlorhexidine in Peri-implantitis Treatment","status":"COMPLETED","sponsor":"University Medical Center Groningen","startDate":"2010-03","conditions":["Periodontal Diseases","Peri-implantitis"],"enrollment":44,"completionDate":"2013-04"},{"nctId":"NCT01521260","phase":"NA","title":"Implant Surface Decontamination in Peri-implantitis Treatment","status":"COMPLETED","sponsor":"University Medical Center Groningen","startDate":"2009-10","conditions":["Peri-implantitis","Periodontal Disease"],"enrollment":30,"completionDate":"2011-09"},{"nctId":"NCT04584684","phase":"PHASE2","title":"Mouth Rinses for Inactivation of COVID-19","status":"TERMINATED","sponsor":"University of North Carolina, Chapel Hill","startDate":"2020-12-18","conditions":["Covid19","Coronavirus Infection","SARS-CoV-2 Infection"],"enrollment":128,"completionDate":"2021-10-21"},{"nctId":"NCT05270382","phase":"NA","title":"Effect of Mouthwashes on Oral Wound Healing and Microbiome","status":"COMPLETED","sponsor":"University of Illinois at Chicago","startDate":"2020-02-01","conditions":["Wound Heal","Oral Microbiome"],"enrollment":34,"completionDate":"2022-12-31"},{"nctId":"NCT05877105","phase":"NA","title":"Effect of Selected Evidence-based Practices and Related Nurses' Education on the Incidence and Severity of Ventilator-associated Pneumonia","status":"COMPLETED","sponsor":"Cairo University","startDate":"2023-05-17","conditions":["Evidence-based Practices","Nursing Education","Incidence","Ventilator-associated Pneumonia"],"enrollment":99,"completionDate":"2023-11-30"},{"nctId":"NCT04409873","phase":"PHASE2","title":"Antiseptic Mouthwash / Pre-Procedural Rinse on SARS-CoV-2 Load (COVID-19)","status":"TERMINATED","sponsor":"University of California, San Francisco","startDate":"2021-03-31","conditions":["COVID-19","SARS-CoV 2","Severe Acute Respiratory Syndrome Coronavirus 2","Virus Disease","Coronavirus Infections","Pharyngeal Diseases"],"enrollment":54,"completionDate":"2022-09-10"},{"nctId":"NCT04723446","phase":"NA","title":"Efficacy of Mouthwashes in Reducing Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Viral Load in the Saliva","status":"COMPLETED","sponsor":"Queen Mary University of London","startDate":"2021-05-19","conditions":["Covid19","Coronavirus"],"enrollment":54,"completionDate":"2021-10-25"},{"nctId":"NCT05802628","phase":"PHASE4","title":"Salivary Drug Concentration Exploratory Study of Cetylpyridinium Chloride Buccal Tablets","status":"COMPLETED","sponsor":"Peking University People's Hospital","startDate":"2023-04-10","conditions":["Pharyngitis Acute","Gingivitis"],"enrollment":10,"completionDate":"2023-04-18"},{"nctId":"NCT01549587","phase":"NA","title":"Oral Hygiene and Maternity Outcomes Multicenter Study (OHMOM)","status":"COMPLETED","sponsor":"Procter and Gamble","startDate":"2012-02","conditions":["Gingivitis","Pregnancy"],"enrollment":746,"completionDate":"2014-04"},{"nctId":"NCT05644236","phase":"NA","title":"Safety and Efficacy Evaluation of Mouth Wash(Glister Mouth Wash): Pilot Study","status":"COMPLETED","sponsor":"Wonju Severance Christian Hospital","startDate":"2021-09-27","conditions":["Oral Hygiene","Gingival Index","Cetylpyridinium Chloride"],"enrollment":86,"completionDate":"2021-12-31"},{"nctId":"NCT04721457","phase":"PHASE4","title":"The Efficacy of Pre-procedural Mouth Rinses on COVID-19 Saliva Viral Load","status":"COMPLETED","sponsor":"King Abdulaziz University","startDate":"2021-01-03","conditions":["SARS-CoV-2","COVID-19","Mouthwashes","Viral Load","Polymerase Chain Reaction","Coronavirus","Covid19","Saliva"],"enrollment":90,"completionDate":"2021-12-10"},{"nctId":"NCT05365737","phase":"NA","title":"Substantivity of Oral Rinses: Comparative Study","status":"COMPLETED","sponsor":"University of Barcelona","startDate":"2022-01-01","conditions":["Prevention & Control"],"enrollment":16,"completionDate":"2022-02-03"},{"nctId":"NCT04902976","phase":"NA","title":"Evaluation of SARS-COV-2 Viral Load of Covid-19 Patients After Rinsing With Oral Antimicrobial Mouthwashes","status":"COMPLETED","sponsor":"Hospital Israelita Albert Einstein","startDate":"2021-04-04","conditions":["Covid19"],"enrollment":105,"completionDate":"2021-10-30"},{"nctId":"NCT04537962","phase":"NA","title":"Salivary SARS-CoV-2 Load of Covid-19 Patients After Oral Antimicrobial Solutions and Dentifrices","status":"COMPLETED","sponsor":"Hospital Israelita Albert Einstein","startDate":"2020-07-14","conditions":["Corona Virus Infection"],"enrollment":202,"completionDate":"2021-09-30"},{"nctId":"NCT04748783","phase":"PHASE2","title":"Antiviral Efficacy and Acceptability of Mouth Rinses for Inactivation of COVID-19","status":"TERMINATED","sponsor":"University of North Carolina, Chapel Hill","startDate":"2021-03-26","conditions":["COVID19","Coronavirus Infection","SARS CoV-2 Infection"],"enrollment":2,"completionDate":"2021-04-07"},{"nctId":"NCT04707742","phase":"NA","title":"Antiseptic Mouth Rinses to Reduce Salivary Viral Load in COVID-19 Patients","status":"COMPLETED","sponsor":"Fundación para el Fomento de la Investigación Sanitaria y Biomédica de la Comunitat Valenciana","startDate":"2020-06-15","conditions":["Covid19"],"enrollment":160,"completionDate":"2021-09-30"},{"nctId":"NCT02575235","phase":"EARLY_PHASE1","title":"Clinical Trial to Assess the Preventive Effects of Cetylpyridinium Chloride on Sarcopenia","status":"COMPLETED","sponsor":"Seoul National University Hospital","startDate":"2015-10-01","conditions":["Sarcopenia"],"enrollment":100,"completionDate":"2016-07-01"},{"nctId":"NCT04757818","phase":"NA","title":"Double-blind, Randomized, Parallel, Placebo-controlled Clinical Study to Evaluate the Viral Load of SARS-CoV-2 (COVID-19) in the Oral Cavity of SARS-CoV-2 Positive Subjects After the Use of a Mouthwash Containing Cetylpyridinium Chloride 0,07%.","status":"COMPLETED","sponsor":"Dentaid SL","startDate":"2021-02-17","conditions":["SARS-CoV-2 Infection"],"enrollment":118,"completionDate":"2021-06-03"},{"nctId":"NCT04820803","phase":"NA","title":"Assessment of the Impact of Oral Intervention With Cetylpyridinium Chloride to Decrease SARS-CoV-2 Viral Load in Patients With COVID-19","status":"COMPLETED","sponsor":"Rosa Tarrago","startDate":"2021-02-03","conditions":["COVID-19","SARS-CoV-2 Infection"],"enrollment":80,"completionDate":"2021-06-30"},{"nctId":"NCT02297997","phase":"EARLY_PHASE1","title":"Preventive Effects of Cetylpyridinium Chloride on SarcopeniaStudy","status":"COMPLETED","sponsor":"Seoul National University Hospital","startDate":"2014-11-13","conditions":["Sarcopenia"],"enrollment":65,"completionDate":"2015-11"},{"nctId":"NCT03219840","phase":"PHASE4","title":"Cetylpyridium Chloride (CPC) Based Chewing Gum and Gingivitis","status":"COMPLETED","sponsor":"The University of Texas Health Science Center, Houston","startDate":"2017-10-18","conditions":["Gingivitis","Plaque, Dental","Periodontal Diseases"],"enrollment":70,"completionDate":"2018-09-08"},{"nctId":"NCT03706781","phase":"PHASE1","title":"A Novel Mouthwash Formulation CTP/BNZ With Mucus Adhesive Polymer","status":"COMPLETED","sponsor":"Aziende Chimiche Riunite Angelini Francesco S.p.A","startDate":"2017-11-14","conditions":["Healthy"],"enrollment":26,"completionDate":"2018-03-30"},{"nctId":"NCT02875769","phase":"PHASE3","title":"Pre-procedural Mouthwash in Reducing Bacteria in Dental Aerosols","status":"COMPLETED","sponsor":"University of Guarulhos","startDate":"2015-02","conditions":["Chronic Periodontitis"],"enrollment":60,"completionDate":"2015-04"},{"nctId":"NCT04383236","phase":"NA","title":"Probiotic Lozenges for Treatment of Recurrent Aphthous Stomatitis","status":"COMPLETED","sponsor":"Reham Lotfy Aggour","startDate":"2016-12-01","conditions":["Oral Ulcer"],"enrollment":120,"completionDate":"2019-04-21"},{"nctId":"NCT01877421","phase":"PHASE1,PHASE2","title":"Safety and Tolerability of Antiplaque Chewing Gum in a Gingivitis Population","status":"COMPLETED","sponsor":"U.S. Army Medical Research and Development Command","startDate":"2014-02-25","conditions":["Plaque","Gingivitis"],"enrollment":135,"completionDate":"2016-03"},{"nctId":"NCT04254835","phase":"PHASE4","title":"Assessment of Inhibition of Biofilm Formation and Plaque Bacterial Count of Fluoride Varnish Containing Chlorhexidine and Cetylpyridinium Chloride Versus Conventional Fluoride Varnish","status":"UNKNOWN","sponsor":"Cairo University","startDate":"2020-02-01","conditions":["High Caries Risk Patients"],"enrollment":34,"completionDate":"2020-08-01"},{"nctId":"NCT02931357","phase":"PHASE3","title":"Study of a New Medical Device in Gel Formulation Versus Calgel® for the Topical Treatment of Teething in Infants","status":"COMPLETED","sponsor":"Ricerfarma S.r.l","startDate":"2013-09","conditions":["Pain Teeth"],"enrollment":54,"completionDate":"2013-12"},{"nctId":"NCT03026205","phase":"PHASE2","title":"ARMS-I (a Formulation of Cetylpyridinium Chloride -CPC)","status":"WITHDRAWN","sponsor":"University of Toledo Health Science Campus","startDate":"2017-01","conditions":["Viral Upper Respiratory Tract Infection"],"enrollment":0,"completionDate":"2017-01"},{"nctId":"NCT02002442","phase":"PHASE2","title":"Dental Implants and Mouth Rinse","status":"COMPLETED","sponsor":"Tufts University","startDate":"2013-11","conditions":["Reduction in Bacterial Counts Through the Use of Mouthwash"],"enrollment":30,"completionDate":"2016-06"},{"nctId":"NCT02665780","phase":"NA","title":"Assessing the Effect of Periodontal Debridement, Tongue Cleaning and Mouth Rinsing for the Treatment of Oral Malodour","status":"WITHDRAWN","sponsor":"University of British Columbia","startDate":"2017-10","conditions":["Halitosis"],"enrollment":0,"completionDate":"2018-10-10"},{"nctId":"NCT03522272","phase":"PHASE4","title":"Effectiveness of an Ultrasonic Denture Hygiene Intervention Program Among Community-dwelling Elders","status":"COMPLETED","sponsor":"The University of Hong Kong","startDate":"2016-06-20","conditions":["Denture","Removable Partial Denture","Denture Cleansers","Cetylpyridinium Chloride"],"enrollment":66,"completionDate":"2017-06-20"},{"nctId":"NCT03179735","phase":"PHASE4","title":"Mouthwashes During Orthodontic Treatment","status":"UNKNOWN","sponsor":"University of Taubate","startDate":"2017-06-01","conditions":["Gingivitis"],"enrollment":60,"completionDate":"2018-07-10"},{"nctId":"NCT02788786","phase":"PHASE2","title":"Feasibility and Acceptability of Use of Daily Oral Rinse in Pregnant Women in Rural Nepal","status":"COMPLETED","sponsor":"Johns Hopkins Bloomberg School of Public Health","startDate":"2016-06-27","conditions":["Periodontitis","Premature Birth of Newborn"],"enrollment":175,"completionDate":"2016-11-15"},{"nctId":"NCT02756377","phase":"PHASE2,PHASE3","title":"A Comparison of Mouth Rinse Containing Alcohol-free Chlorhexidine With a Cetylpyridinium Chloride in Periodontal Diseases","status":"COMPLETED","sponsor":"Islamic Azad University, Sanandaj","startDate":"2014-05","conditions":["Periodontal Diseases"],"enrollment":34,"completionDate":"2015-06"},{"nctId":"NCT02366689","phase":"PHASE4","title":"Clinical Study Comparing Dental Plaque and Gingivitis Reduction After Using One of Three Oral Hygiene Multi-component Regimens (Using of a Manual Toothbrush, a Toothpaste and a Mouthwash)","status":"COMPLETED","sponsor":"Colgate Palmolive","startDate":"2014-06","conditions":["Dental Plaque","Gingivitis"],"enrollment":179,"completionDate":"2014-12"},{"nctId":"NCT02360995","phase":"PHASE4","title":"The Clinical Investigation of Toothpaste as Compared to Toothpaste and Mouthwash in Reducing Plaque and Gingivitis: A Six-week Clinical Study in the US","status":"COMPLETED","sponsor":"Colgate Palmolive","startDate":"2014-06","conditions":["Dental Plaque","Gingivitis"],"enrollment":129,"completionDate":"2014-08"},{"nctId":"NCT02193165","phase":"PHASE3","title":"The Clinical Efficacy of Three Oral Hygiene Regimens Using a Manual Toothbrush, Toothpaste and a Mouthwash in Controlling Dental Plaque and Gingivitis","status":"COMPLETED","sponsor":"Colgate Palmolive","startDate":"2014-07","conditions":["Dental Plaque","Gingivitis"],"enrollment":120,"completionDate":"2014-08"},{"nctId":"NCT02194023","phase":"PHASE2","title":"Clinical Effects of Two New Chlorhexidine Digluconate Formulations: 0.12% and 0.03%.","status":"COMPLETED","sponsor":"Universitat Internacional de Catalunya","startDate":"2011-09","conditions":["Dental Plaque","Side Effects"],"enrollment":200,"completionDate":"2013-07"},{"nctId":"NCT01695187","phase":"PHASE3","title":"NB-001 Treatment of Recurrent Herpes Labialis","status":"UNKNOWN","sponsor":"NanoBio Corporation","startDate":"2012-10","conditions":["Herpes Labialis"],"enrollment":362,"completionDate":"2013-07"},{"nctId":"NCT01265446","phase":"PHASE3","title":"Efficacy and Safety of a Sore Throat Lozenge Containing Lidocaine and Cetylpyridinium Chloride in Patients With Sore Throat Due to a Common Cold.","status":"COMPLETED","sponsor":"Novartis","startDate":"2010-12","conditions":["Sore Throat Due to a Common Cold"],"enrollment":250,"completionDate":"2011-04"},{"nctId":"NCT01657396","phase":"NA","title":"Implementation and Evaluation of Revised Protocols for Oral Hygiene for Mechanically Ventilated Patients","status":"COMPLETED","sponsor":"University of Calgary","startDate":"2012-07","conditions":["Ventilator Associated Pneumonia","Oral Hygiene"],"enrollment":150,"completionDate":"2012-11"},{"nctId":"NCT00855933","phase":"PHASE4","title":"A Controlled Clinical Study to Determine the Gingivitis Benefit of Flossing","status":"COMPLETED","sponsor":"Procter and Gamble","startDate":"2009-01","conditions":["Gingivitis"],"enrollment":60,"completionDate":"2009-02"},{"nctId":"NCT01580943","phase":"PHASE1,PHASE2","title":"Efficacy of Two Commercially Available Chlorhexidine Mouthrinses Non-alcohol Base","status":"COMPLETED","sponsor":"Universidade do Porto","startDate":"2011-10","conditions":["Dental Plaque"],"enrollment":50,"completionDate":"2012-03"},{"nctId":"NCT00729599","phase":"PHASE3","title":"Safety Dermatological Evaluation: Acceptability With Odontological Follow up - Cepacol Teen.","status":"COMPLETED","sponsor":"Sanofi","startDate":"2008-07","conditions":["Hygiene"],"enrollment":31,"completionDate":""},{"nctId":"NCT00687037","phase":"PHASE3","title":"Safety Oral Mucosa Evaluation - Acceptability With Odontological Follow up - Cepacol Canela Power","status":"COMPLETED","sponsor":"Sanofi","startDate":"2008-01","conditions":["Healthy"],"enrollment":30,"completionDate":""},{"nctId":"NCT00416286","phase":"","title":"Effect of Sustained-Release Cetylpyridinium Chloride Varnish on Streptococcus Mutans and Lactobacillus in Orthodontic Patients","status":"UNKNOWN","sponsor":"Hadassah Medical Organization","startDate":"","conditions":["Healthy"],"enrollment":30,"completionDate":""}],"genericFilers":[],"latestUpdates":[],"manufacturing":[],"administration":{"route":"Oral","formulation":"Cloth, Liquid","formulations":[{"form":"CLOTH","route":"EXTRACORPOREAL","productName":"Disinfectant Wipes"},{"form":"CLOTH","route":"TOPICAL","productName":"Alcohol Wipes"},{"form":"CLOTH","route":"TOPICAL","productName":"CART CLEANING WIPES"},{"form":"CLOTH","route":"TOPICAL","productName":"Disinfect Wipes"},{"form":"CLOTH","route":"TOPICAL","productName":"Disinfectant wet wipe"},{"form":"CLOTH","route":"TOPICAL","productName":"Niguo Disinfectant wipes-80 Sheets"},{"form":"CLOTH","route":"TOPICAL","productName":"Sanitize/Disinfect Wipes"},{"form":"LIQUID","route":"DENTAL","productName":"OptiRinse Plus"},{"form":"LIQUID","route":"DENTAL","productName":"Oral-BAnti-Bacterial"},{"form":"LIQUID","route":"DENTAL","productName":"COOL SENSE STICK GARGLE"},{"form":"LIQUID","route":"DENTAL","productName":"Denti Whoo Bubble Concentrated Gargle"},{"form":"LIQUID","route":"DENTAL","productName":"E-zen Gargle"},{"form":"LIQUID","route":"ORAL","productName":"Cepacol Antibacterial"},{"form":"LIQUID","route":"ORAL","productName":"Antispetic"},{"form":"LIQUID","route":"ORAL","productName":"CloSYS Silver Healthy Gums"}]},"crossReferences":{"NUI":"N0000147763","MMSL":"4401","NDDF":"003144","UNII":"CUB7JI0JV3","VUID":"4019671","CHEBI":"CHEBI:32915","VANDF":"4019096","RXNORM":"2286","UMLSCUI":"C0007906","chemblId":"CHEMBL2003538","ChEMBL_ID":"CHEMBL305906","KEGG_DRUG":"D07666","DRUGBANK_ID":"DB11073","PUBCHEM_CID":"2683","SNOMEDCT_US":"11719000","SECONDARY_CAS_RN":"6004-24-6","MESH_DESCRIPTOR_UI":"D002594"},"formularyStatus":[],"_enricherVersion":"v2","developmentCodes":[],"ownershipHistory":[],"publicationCount":1911,"therapeuticAreas":["Pain"],"atcClassification":{"source":"DrugCentral","atcCode":"B05CA01","allCodes":["B05CA01","D08AJ03","D09AA07","R02AA06"]},"biosimilarFilings":[],"recentPublications":[{"date":"2026 Mar 17","pmid":"41867590","title":"Kaolin-Gallic Acid Functionalized Gamma-Chitosan/Alginate Beads: A Novel Material for Chlorhexidine and Cetylpyridinium Elimination from Dental Effluents.","journal":"ACS omega"},{"date":"2026 Apr","pmid":"41862273","title":"Antiviral effect of cetylpyridinium chloride on SARS-CoV-2 in patients with COVID-19: An Observational Study.","journal":"Journal of oral biosciences"},{"date":"2026 Mar 19","pmid":"41852227","title":"Interaction of Bile Salts, Surfactants, and Their Mixtures with the Phosphatidylcholine(d(62)) Lipid Monolayer/Water Interface Probed by VSFG Spectroscopy.","journal":"Langmuir : the ACS journal of surfaces and colloids"},{"date":"2026 Mar 19","pmid":"41851409","title":"Structural and dynamic characterisation of charged microemulsions grafted with telechelic polymers at high dilution.","journal":"The European physical journal. E, Soft matter"},{"date":"2026 Mar 17","pmid":"41843575","title":"Effect of Cationic Surfactants on the Molecular Organization of the Simplified Model Lipid Envelope of SARS-CoV-2 Virus─Insights from the Langmuir Monolayer and Liposome Studies.","journal":"Langmuir : the ACS journal of surfaces and colloids"}],"companionDiagnostics":[],"genericManufacturerList":[],"status":"active","companyName":"","companyId":"","modality":"Small molecule","firstApprovalDate":"","aiSummary":"","enrichmentLevel":3,"visitCount":0,"regulatoryByCountry":[{"country_code":"US","regulator":"FDA","status":"approved","approval_date":null,"mah":"","brand_name_local":null,"application_number":""},{"country_code":"CA","regulator":"Health Canada","status":"approved","approval_date":null,"mah":"","brand_name_local":"","application_number":""},{"country_code":"BR","regulator":"ANVISA","status":"likely_approved","approval_date":null,"mah":null,"brand_name_local":null,"application_number":null},{"country_code":"MX","regulator":"COFEPRIS","status":"likely_approved","approval_date":null,"mah":null,"brand_name_local":null,"application_number":null},{"country_code":"AR","regulator":"ANMAT","status":"likely_approved","approval_date":null,"mah":null,"brand_name_local":null,"application_number":null},{"country_code":"TR","regulator":"TITCK","status":"likely_approved","approval_date":null,"mah":null,"brand_name_local":null,"application_number":null},{"country_code":"IN","regulator":"CDSCO","status":"likely_approved","approval_date":null,"mah":null,"brand_name_local":null,"application_number":null},{"country_code":"TH","regulator":"FDA-TH","status":"likely_approved","approval_date":null,"mah":null,"brand_name_local":null,"application_number":null},{"country_code":"MY","regulator":"NPRA","status":"likely_approved","approval_date":null,"mah":null,"brand_name_local":null,"application_number":null},{"country_code":"PH","regulator":"FDA-PH","status":"likely_approved","approval_date":null,"mah":null,"brand_name_local":null,"application_number":null},{"country_code":"CO","regulator":"INVIMA","status":"likely_approved","approval_date":null,"mah":null,"brand_name_local":null,"application_number":null},{"country_code":"ZA","regulator":"SAHPRA","status":"likely_approved","approval_date":null,"mah":null,"brand_name_local":null,"application_number":null},{"country_code":"TW","regulator":"TFDA","status":"likely_approved","approval_date":null,"mah":null,"brand_name_local":null,"application_number":null},{"country_code":"HK","regulator":"DH","status":"likely_approved","approval_date":null,"mah":null,"brand_name_local":null,"application_number":null},{"country_code":"IL","regulator":"MOH","status":"likely_approved","approval_date":null,"mah":null,"brand_name_local":null,"application_number":null},{"country_code":"SG","regulator":"HSA","status":"likely_approved","approval_date":null,"mah":null,"brand_name_local":null,"application_number":null},{"country_code":"AE","regulator":"MOH","status":"likely_approved","approval_date":null,"mah":null,"brand_name_local":null,"application_number":null},{"country_code":"KR","regulator":"MFDS","status":"likely_approved","approval_date":null,"mah":null,"brand_name_local":null,"application_number":null},{"country_code":"AU","regulator":"TGA","status":"likely_approved","approval_date":null,"mah":null,"brand_name_local":null,"application_number":null},{"country_code":"GB","regulator":"MHRA","status":"likely_approved","approval_date":null,"mah":null,"brand_name_local":null,"application_number":null}],"trialStats":{"total":5,"withResults":0},"validation":{"fieldsValidated":0,"lastValidatedAt":"2026-04-20T00:18:58.293594+00:00","fieldsConflicting":16,"overallConfidence":0.8},"verificationStatus":"verified","dataCompleteness":{"mechanism":false,"indications":true,"safety":true,"trials":true,"score":3}}